GILD logo

Gilead Sciences, Inc. (GILD) EBITDA

Annual EBITDA:

$1.67B-$8.83B(-84.12%)
December 31, 2024

Summary

  • As of today, GILD annual EBITDA is $1.67 billion, with the most recent change of -$8.83 billion (-84.12%) on December 31, 2024.
  • During the last 3 years, GILD annual EBITDA has fallen by -$9.66 billion (-85.29%).
  • GILD annual EBITDA is now -92.89% below its all-time high of $23.45 billion, reached on December 31, 2015.

Performance

GILD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

Quarterly EBITDA:

$4.21B+$770.00M(+22.35%)
September 30, 2025

Summary

  • As of today, GILD quarterly EBITDA is $4.21 billion, with the most recent change of +$770.00 million (+22.35%) on September 30, 2025.
  • Over the past year, GILD quarterly EBITDA has increased by +$363.00 million (+9.42%).
  • GILD quarterly EBITDA is now -26.94% below its all-time high of $5.77 billion, reached on June 30, 2015.

Performance

GILD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

TTM EBITDA:

$14.10B+$363.00M(+2.64%)
September 30, 2025

Summary

  • As of today, GILD TTM EBITDA is $14.10 billion, with the most recent change of +$363.00 million (+2.64%) on September 30, 2025.
  • Over the past year, GILD TTM EBITDA has increased by +$754.00 million (+5.65%).
  • GILD TTM EBITDA is now -38.02% below its all-time high of $22.75 billion, reached on December 31, 2015.

Performance

GILD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

GILD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-84.1%+9.4%+5.7%
3Y3 Years-85.3%+12.9%+17.7%
5Y5 Years-78.0%+19.9%+48.1%

GILD EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-85.3%at lowat high+63.4%at high+18.7%
5Y5-Year-85.3%at low-3.3%+111.0%-1.1%+48.1%
All-TimeAll-Time-92.9%+1672.7%-26.9%+464.3%-38.0%>+9999.0%

GILD EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$4.21B(+22.4%)
$14.10B(+2.6%)
Jun 2025
-
$3.44B(+6.3%)
$13.74B(+0.5%)
Mar 2025
-
$3.24B(+1.2%)
$13.68B(+1.9%)
Dec 2024
$1.67B(-84.1%)
$3.20B(-16.9%)
$13.43B(+0.6%)
Sep 2024
-
$3.85B(+13.9%)
$13.35B(+3.7%)
Jun 2024
-
$3.38B(+13.0%)
$12.88B(+6.6%)
Mar 2024
-
$2.99B(-4.2%)
$12.07B(+1.6%)
Dec 2023
$10.50B(+18.6%)
$3.12B(-7.6%)
$11.88B(-1.5%)
Sep 2023
-
$3.38B(+31.0%)
$12.06B(-2.8%)
Jun 2023
-
$2.58B(-7.8%)
$12.41B(-2.0%)
Mar 2023
-
$2.80B(-15.2%)
$12.67B(-4.6%)
Dec 2022
$8.85B(-21.9%)
$3.30B(-11.6%)
$13.28B(+10.9%)
Sep 2022
-
$3.73B(+31.5%)
$11.98B(-5.0%)
Jun 2022
-
$2.84B(-16.7%)
$12.61B(-0.7%)
Mar 2022
-
$3.41B(+70.7%)
$12.70B(-0.4%)
Dec 2021
$11.33B(+174.1%)
$2.00B(-54.2%)
$12.75B(-10.6%)
Sep 2021
-
$4.36B(+48.9%)
$14.26B(+6.3%)
Jun 2021
-
$2.93B(-15.4%)
$13.41B(+8.5%)
Mar 2021
-
$3.46B(-1.4%)
$12.36B(+6.3%)
Dec 2020
$4.13B(-45.3%)
$3.51B(-0.1%)
$11.62B(+22.0%)
Sep 2020
-
$3.51B(+87.6%)
$9.52B(+96.3%)
Jun 2020
-
$1.87B(-31.2%)
$4.85B(-15.2%)
Mar 2020
-
$2.72B(+92.9%)
$5.72B(+2.8%)
Dec 2019
$7.56B(-26.6%)
$1.41B(+222.0%)
$5.56B(-13.9%)
Sep 2019
-
-$1.16B(-142.2%)
$6.46B(-39.1%)
Jun 2019
-
$2.74B(+6.8%)
$10.61B(+0.6%)
Mar 2019
-
$2.57B(+11.2%)
$10.54B(+0.1%)
Dec 2018
$10.30B(-35.3%)
$2.31B(-22.8%)
$10.54B(-5.3%)
Sep 2018
-
$2.99B(+11.5%)
$11.12B(-9.3%)
Jun 2018
-
$2.68B(+4.8%)
$12.27B(-13.2%)
Mar 2018
-
$2.56B(-11.5%)
$14.12B(-9.4%)
Dec 2017
$15.93B(-17.1%)
$2.89B(-30.1%)
$15.58B(-8.5%)
Sep 2017
-
$4.13B(-8.9%)
$17.02B(-5.0%)
Jun 2017
-
$4.54B(+13.0%)
$17.91B(-3.7%)
Mar 2017
-
$4.02B(-7.2%)
$18.61B(-4.3%)
Dec 2016
$19.22B(-18.0%)
$4.33B(-13.8%)
$19.43B(-6.9%)
Sep 2016
-
$5.02B(-4.0%)
$20.87B(-3.2%)
Jun 2016
-
$5.23B(+7.9%)
$21.57B(-2.4%)
Mar 2016
-
$4.85B(-15.9%)
$22.11B(-2.8%)
Dec 2015
$23.45B(+43.7%)
$5.77B(+0.7%)
$22.75B(+5.5%)
Sep 2015
-
$5.72B(-0.8%)
$21.58B(+10.1%)
Jun 2015
-
$5.77B(+5.0%)
$19.60B(+5.7%)
Mar 2015
-
$5.50B(+19.7%)
$18.53B(+13.4%)
Dec 2014
$16.32B(+235.8%)
$4.59B(+22.5%)
$16.35B(+24.6%)
Sep 2014
-
$3.75B(-20.4%)
$13.12B(+23.5%)
Jun 2014
-
$4.70B(+42.2%)
$10.62B(+48.5%)
Mar 2014
-
$3.31B(+143.4%)
$7.15B(+44.5%)
Dec 2013
$4.86B(+14.3%)
$1.36B(+8.7%)
$4.95B(+2.7%)
Sep 2013
-
$1.25B(+1.4%)
$4.82B(+2.5%)
Jun 2013
-
$1.23B(+11.6%)
$4.70B(+2.6%)
Mar 2013
-
$1.11B(-9.9%)
$4.58B(+5.7%)
Dec 2012
$4.25B(+2.2%)
$1.23B(+8.1%)
$4.33B(+6.4%)
Sep 2012
-
$1.13B(+1.8%)
$4.07B(+0.3%)
Jun 2012
-
$1.11B(+29.9%)
$4.06B(+0.0%)
Mar 2012
-
$857.86M(-11.1%)
$4.06B(-2.8%)
Dec 2011
$4.16B(-3.0%)
$964.46M(-13.9%)
$4.17B(+1.3%)
Sep 2011
-
$1.12B(+0.7%)
$4.12B(+2.6%)
Jun 2011
-
$1.11B(+14.3%)
$4.01B(+2.3%)
Mar 2011
-
$972.95M(+6.8%)
$3.92B(-6.2%)
Dec 2010
$4.29B(+13.3%)
$910.86M(-10.4%)
$4.18B(-5.6%)
Sep 2010
-
$1.02B(-0.4%)
$4.43B(+1.7%)
Jun 2010
-
$1.02B(-17.0%)
$4.35B(+5.1%)
Mar 2010
-
$1.23B(+6.3%)
$4.14B(+11.3%)
Dec 2009
$3.78B(+30.8%)
$1.16B(+22.7%)
$3.72B(+12.7%)
Sep 2009
-
$943.34M(+16.4%)
$3.30B(+7.0%)
Jun 2009
-
$810.76M(+0.1%)
$3.09B(+5.8%)
Mar 2009
-
$809.65M(+9.7%)
$2.92B(+4.5%)
Dec 2008
$2.89B(+30.6%)
$737.98M(+1.3%)
$2.79B(+8.3%)
Sep 2008
-
$728.50M(+13.7%)
$2.58B(+6.9%)
Jun 2008
-
$640.60M(-6.5%)
$2.41B(+3.6%)
Mar 2008
-
$684.78M(+30.7%)
$2.33B(+5.1%)
DateAnnualQuarterlyTTM
Dec 2007
$2.22B(+31.7%)
$523.95M(-6.9%)
$2.22B(+1.2%)
Sep 2007
-
$562.56M(+0.9%)
$2.19B(+6.7%)
Jun 2007
-
$557.46M(-2.5%)
$2.05B(+9.6%)
Mar 2007
-
$571.82M(+15.1%)
$1.87B(+10.7%)
Dec 2006
$1.68B(+47.0%)
$496.99M(+17.0%)
$1.69B(+7.9%)
Sep 2006
-
$424.79M(+12.4%)
$1.57B(+11.0%)
Jun 2006
-
$377.90M(-3.3%)
$1.41B(+7.2%)
Mar 2006
-
$390.80M(+4.5%)
$1.32B(+14.0%)
Dec 2005
$1.14B(+75.6%)
$373.90M(+38.7%)
$1.16B(+21.2%)
Sep 2005
-
$269.62M(-4.8%)
$953.10M(+11.7%)
Jun 2005
-
$283.19M(+23.9%)
$853.37M(+16.2%)
Mar 2005
-
$228.57M(+33.1%)
$734.39M(+11.9%)
Dec 2004
$651.79M(+85.8%)
$171.73M(+1.1%)
$656.10M(+11.4%)
Sep 2004
-
$169.89M(+3.5%)
$588.72M(+17.0%)
Jun 2004
-
$164.21M(+9.3%)
$503.16M(+11.4%)
Mar 2004
-
$150.27M(+44.0%)
$451.67M(+25.1%)
Dec 2003
$350.78M(+267.6%)
$104.35M(+23.8%)
$361.00M(+23.1%)
Sep 2003
-
$84.33M(-25.2%)
$293.38M(+17.0%)
Jun 2003
-
$112.72M(+89.1%)
$250.72M(+56.1%)
Mar 2003
-
$59.60M(+62.3%)
$160.62M(+64.8%)
Dec 2002
$95.44M(+190.0%)
$36.73M(-11.8%)
$97.44M(+137.5%)
Sep 2002
-
$41.66M(+84.1%)
$41.03M(+224.7%)
Jun 2002
-
$22.63M(+731.2%)
-$32.91M(+61.7%)
Mar 2002
-
-$3.58M(+81.8%)
-$85.83M(+17.9%)
Dec 2001
-$106.00M(-163.0%)
-$19.68M(+39.0%)
-$104.60M(-4.9%)
Sep 2001
-
-$32.27M(-6.6%)
-$99.75M(-16.4%)
Jun 2001
-
-$30.29M(-35.5%)
-$85.70M(-47.5%)
Mar 2001
-
-$22.36M(-50.8%)
-$58.12M(-46.0%)
Dec 2000
-$40.31M(-3.1%)
-$14.83M(+18.7%)
-$39.81M(-25.7%)
Sep 2000
-
-$18.23M(-575.0%)
-$31.68M(-45.5%)
Jun 2000
-
-$2.70M(+33.3%)
-$21.77M(+39.1%)
Mar 2000
-
-$4.05M(+39.6%)
-$35.75M(+28.9%)
Dec 1999
-$39.10M(+39.9%)
-$6.70M(+19.5%)
-$50.27M(+20.6%)
Sep 1999
-
-$8.32M(+50.1%)
-$63.34M(+16.7%)
Jun 1999
-
-$16.69M(+10.1%)
-$76.02M(+3.1%)
Mar 1999
-
-$18.57M(+6.1%)
-$78.48M(-9.7%)
Dec 1998
-$65.10M(-14.4%)
-$19.77M(+5.8%)
-$71.57M(+13.3%)
Sep 1998
-
-$20.99M(-9.6%)
-$82.50M(-8.8%)
Jun 1998
-
-$19.16M(-64.4%)
-$75.81M(-32.2%)
Mar 1998
-
-$11.65M(+62.0%)
-$57.35M(-1.0%)
Dec 1997
-$56.90M(-80.1%)
-$30.70M(-114.7%)
-$56.80M(-51.1%)
Sep 1997
-
-$14.30M(-1942.9%)
-$37.60M(-121.2%)
Jun 1997
-
-$700.00K(+93.7%)
-$17.00M(+44.1%)
Mar 1997
-
-$11.10M(+3.5%)
-$30.40M(+3.5%)
Dec 1996
-$31.60M(-9.7%)
-$11.50M(-282.5%)
-$31.50M(-57.5%)
Sep 1996
-
$6.30M(+144.7%)
-$20.00M(+43.0%)
Jun 1996
-
-$14.10M(-15.6%)
-$35.10M(-21.5%)
Mar 1996
-
-$12.20M(-38.6%)
-$28.90M(+9.7%)
Dec 1995
-$28.80M(-7.9%)
-
-
Sep 1995
-
-$8.80M(-11.4%)
-$32.00M(-6.0%)
Jun 1995
-
-$7.90M(+11.2%)
-$30.20M(-2.4%)
Mar 1995
-
-$8.90M(-39.1%)
-$29.50M(-2.1%)
Dec 1994
-
-$6.40M(+8.6%)
-$28.90M(+1.0%)
Sep 1994
-
-$7.00M(+2.8%)
-$29.20M(-3.2%)
Jun 1994
-
-$7.20M(+13.3%)
-$28.30M(-7.2%)
Mar 1994
-$26.70M(-61.8%)
-$8.30M(-23.9%)
-$26.40M(-7.3%)
Dec 1993
-
-$6.70M(-9.8%)
-$24.60M(-11.8%)
Sep 1993
-
-$6.10M(-15.1%)
-$22.00M(-14.6%)
Jun 1993
-
-$5.30M(+18.5%)
-$19.20M(-17.8%)
Mar 1993
-$16.50M(-211.3%)
-$6.50M(-58.5%)
-$16.30M(+4.1%)
Dec 1992
-
-$4.10M(-24.2%)
-$17.00M(-37.1%)
Sep 1992
-
-$3.30M(-37.5%)
-$12.40M(-39.3%)
Jun 1992
-
-$2.40M(+66.7%)
-$8.90M(-41.3%)
Mar 1992
-$5.30M(-32.5%)
-$7.20M(-1540.0%)
-$6.30M(-57.5%)
Dec 1991
-
$500.00K(+150.0%)
-$4.00M(+9.1%)
Sep 1991
-
$200.00K(0.0%)
-$4.40M(+2.2%)
Jun 1991
-
$200.00K(+104.1%)
-$4.50M(+2.2%)
Mar 1991
-$4.00M
-$4.90M(-5000.0%)
-$4.60M(-1633.3%)
Dec 1990
-
$100.00K(0.0%)
$300.00K(+50.0%)
Sep 1990
-
$100.00K(0.0%)
$200.00K(+100.0%)
Jun 1990
-
$100.00K
$100.00K

FAQ

  • What is Gilead Sciences, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Gilead Sciences, Inc.?
  • What is Gilead Sciences, Inc. annual EBITDA year-on-year change?
  • What is Gilead Sciences, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Gilead Sciences, Inc.?
  • What is Gilead Sciences, Inc. quarterly EBITDA year-on-year change?
  • What is Gilead Sciences, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Gilead Sciences, Inc.?
  • What is Gilead Sciences, Inc. TTM EBITDA year-on-year change?

What is Gilead Sciences, Inc. annual EBITDA?

The current annual EBITDA of GILD is $1.67B

What is the all-time high annual EBITDA for Gilead Sciences, Inc.?

Gilead Sciences, Inc. all-time high annual EBITDA is $23.45B

What is Gilead Sciences, Inc. annual EBITDA year-on-year change?

Over the past year, GILD annual EBITDA has changed by -$8.83B (-84.12%)

What is Gilead Sciences, Inc. quarterly EBITDA?

The current quarterly EBITDA of GILD is $4.21B

What is the all-time high quarterly EBITDA for Gilead Sciences, Inc.?

Gilead Sciences, Inc. all-time high quarterly EBITDA is $5.77B

What is Gilead Sciences, Inc. quarterly EBITDA year-on-year change?

Over the past year, GILD quarterly EBITDA has changed by +$363.00M (+9.42%)

What is Gilead Sciences, Inc. TTM EBITDA?

The current TTM EBITDA of GILD is $14.10B

What is the all-time high TTM EBITDA for Gilead Sciences, Inc.?

Gilead Sciences, Inc. all-time high TTM EBITDA is $22.75B

What is Gilead Sciences, Inc. TTM EBITDA year-on-year change?

Over the past year, GILD TTM EBITDA has changed by +$754.00M (+5.65%)
On this page